ASX 200 (ASX:XJO) midday update: Macquarie doubles profit, ResMed jumps

Here’s what is happening on the ASX 200 today…
The post ASX 200 (ASX:XJO) midday update: Macquarie doubles profit, ResMed jumps appeared first on The Motley Fool Australia. –

At lunch on Friday, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a disappointing decline. The benchmark index is currently down 0.55% to 7,389.1 points.

Here’s what is happening on the ASX 200 today:

Macquarie delivers strong half year result

The Macquarie Group Ltd (ASX: MQG) share price is in a trading halt on Friday. This follows the announcement of a $1.5 billion capital raising along with its half year results. In respect to the latter, the investment bank reported a first half net profit up 107% to $2,043 million. A key driver of its strong performance was the Macquarie Capital business. It delivered a net profit contribution of $468 million, up significantly from a loss of $189 million in the first half of FY 2021.

ResMed’s Q1 results beats expectations

The ResMed (ASX: RMD) share price is charging higher today after delivering a first quarter result ahead of the market’s expectations. The sleep treatment focused medical device company reported a 20% increase in revenue to US$904 million and GAAP earnings per share of US$1.39. This compares to consensus estimates of US$860 million and US$1.24 per share, respectively.

NAB director appointment U-turn

The National Australia Bank Ltd (ASX: NAB) share price is trading lower than the rest of the big four banks today. This may relate to news that James Spenceley will no longer be joining the bank as a Non-Executive Director. NAB Chair Philip Chronican revealed that Mr Spenceley decided against the move after reconsidering his overall commitments following feedback from proxy advisors as well as a number of NAB investors.

Best and worst ASX 200 performers

The best performer on the ASX 200 on Friday has been the Reece Ltd (ASX: REH) share price with a 7% gain. This morning the plumbing parts company released its first quarter update and revealed sales growth of 13.2%. The worst performer has been the Pointsbet Holdings Ltd (ASX: PBH) share price with a 9% decline. Investors have been selling the sports betting company’s shares since the release of its quarterly update. Goldman Sachs believes this is a buying opportunity.

The post ASX 200 (ASX:XJO) midday update: Macquarie doubles profit, ResMed jumps appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of August 16th 2021

More reading

PointsBet (ASX:PBH) share price extends losses on Friday, down 25% this week

The biggest risk to global growth and ASX 200 returns in 2022

JB Hi-Fi (ASX:JBH) share price jumps on broker upgrade

Why Goldman says PointsBet (ASX:PBH) share price sell off is a buying opportunity

NAB (ASX:NAB) share price lower following director announcement

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Pointsbet Holdings Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool Australia has recommended Pointsbet Holdings Ltd and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!